Interleukin-6 Enhances Murine Megakaryocytopoiesis in Serum-free Culture
Overview
Authors
Affiliations
We investigated the effect of interleukin-6 (IL-6) on murine megakaryocytopoiesis in a serum-free culture system. The addition of IL-6 to a culture containing interleukin-3 (IL-3) resulted in a significant increase in the number of megakaryocyte colonies by bone marrow cells of normal mice. The megakaryocytic progenitors that survive exposure to 5-fluorouracil (5-FU) exhibited a more significant response to IL-6 and IL-3. Polyclonal anti-IL-6 antibody neutralized the stimulatory effect of IL-6 on megakaryocyte colony growth supported by IL-3. Delayed addition experiments and replating experiments of blast cell colonies showed that megakaryocytic progenitors are supported by IL-3 in the early stage of the development but require IL-6 for their subsequent proliferation and differentiation. In addition, IL-6 increased the size of megakaryocytes in granulocyte-macrophage-megakaryocyte colonies. The combination of granulocyte colony-stimulating factor or granulocyte-macrophage colony stimulating factor with IL-3 resulted in an increase in the granulocyte-macrophage colony growth of bone marrow cells of 5-FU-treated mice or normal mice, respectively, but had little effect on the enhancement of pure and mixed megakaryocyte colony growth. These results suggest that IL-6 plays an important role in murine megakaryocytopoiesis.
Interleukin 6 Antagonists in Severe COVID-19 Disease: Cardiovascular and Respiratory Outcomes.
Khan S Protein Pept Lett. 2024; 31(3):178-191.
PMID: 38375841 DOI: 10.2174/0109298665266730240118054023.
Designer cytokine hyper interleukin 11 (H11) is a megakaryopoietic factor.
Dams-Kozlowska H, Kwiatkowska-Borowczyk E, Gryska K, Mackiewicz A Int J Med Sci. 2013; 10(9):1157-65.
PMID: 23869192 PMC: 3714392. DOI: 10.7150/ijms.5638.
Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase.
Eliades A, Papadantonakis N, Bhupatiraju A, Burridge K, Johnston-Cox H, Migliaccio A J Biol Chem. 2011; 286(31):27630-8.
PMID: 21665949 PMC: 3149354. DOI: 10.1074/jbc.M111.243113.
IL-6: from laboratory to bedside.
Kishimoto T Clin Rev Allergy Immunol. 2005; 28(3):177-86.
PMID: 16129902 DOI: 10.1385/CRIAI:28:3:177.
The paradigm of IL-6: from basic science to medicine.
Naka T, Nishimoto N, Kishimoto T Arthritis Res. 2002; 4 Suppl 3:S233-42.
PMID: 12110143 PMC: 3240141. DOI: 10.1186/ar565.